CD274 and hepatocellular carcinoma: Since PD-L1 expression on tumor cells has been used widely as a predictive marker for efficacy of ICI therapy, to further analyze the relationship, the expression of BAP1 and PD-L1 in HCC tissues were assessed by immunohistochemistry staining of human HCC tissue microarray (Figure 5C).